95 related articles for article (PubMed ID: 23339665)
21. [Compound Xuanju capsule improves sex hormones and sex organ indexes in castrated male rats].
Zhou SH; Weng ZW; Chen YQ; Li L; Fang YQ
Zhonghua Nan Ke Xue; 2011 Oct; 17(10):953-6. PubMed ID: 22049804
[TBL] [Abstract][Full Text] [Related]
22. [Hormone replacement Up-to-date. LOH and testosterone replacement therapy: clinical application].
Yasuda M
Clin Calcium; 2007 Sep; 17(9):1326-33. PubMed ID: 17767020
[TBL] [Abstract][Full Text] [Related]
23. Multi-Institutional Survey of Medical Treatment for Late-Onset Hypogonadism in Japan.
Taniguchi H; Matsuda T
Am J Mens Health; 2017 Mar; 11(2):376-379. PubMed ID: 27923967
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin and testosterone in patients with symptoms of late-onset hypogonadism: is there a link?
Tsujimura A; Takada S; Matsuoka Y; Nakayama J; Takao T; Miyagawa Y; Sonoda M; Nishizawa H; Iwahashi H; Funahashi T; Nonomura N; Okuyama A
Int J Urol; 2009 Oct; 16(10):830-5. PubMed ID: 19719531
[TBL] [Abstract][Full Text] [Related]
25. [Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].
Nieuwenhuijzen Kruseman AC
Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1925-8. PubMed ID: 16999276
[TBL] [Abstract][Full Text] [Related]
26. Testosterone deficiency in older men: a problem worth treating.
McHenry Martin C
Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of the statues of patients visiting our specialized clinic for hypogonadal men: 5-year experience].
Kawa G; Taniguchi H; Kinoshita H; Matsuda T
Hinyokika Kiyo; 2009 Feb; 55(2):87-92. PubMed ID: 19301613
[TBL] [Abstract][Full Text] [Related]
28. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
Yatkin E; Bernoulli J; Talvitie EM; Santti R
Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173
[TBL] [Abstract][Full Text] [Related]
29. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
[TBL] [Abstract][Full Text] [Related]
30. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
La Vignera S; Calogero AE; D'Agata R; Di Mauro M; Tumino S; Condorelli R; Lanzafame F; Finocchiaro C; Giammusso B; Vicari E
Minerva Endocrinol; 2008 Sep; 33(3):159-67. PubMed ID: 18846023
[TBL] [Abstract][Full Text] [Related]
31. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
32. [Testosterone in old age: an up-date].
Hilbert-Walter A; Büttner R; Sieber C; Bollheimer C
Dtsch Med Wochenschr; 2012 Oct; 137(41):2117-22. PubMed ID: 23033170
[TBL] [Abstract][Full Text] [Related]
33. Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients.
Ferreira U; Leitao VA; Denardi F; Matheus WE; Stopiglia RM; Netto NR
Prostate Cancer Prostatic Dis; 2006; 9(1):39-41. PubMed ID: 16276352
[TBL] [Abstract][Full Text] [Related]
34. Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor.
Murakami Y; Zhao Q; Harada K; Tohda M; Watanabe H; Matsumoto K
Pharmacol Biochem Behav; 2005 Jul; 81(3):616-25. PubMed ID: 15936808
[TBL] [Abstract][Full Text] [Related]
35. Standardised water-soluble extract of Eurycoma longifolia, Tongkat ali, as testosterone booster for managing men with late-onset hypogonadism?
Tambi MI; Imran MK; Henkel RR
Andrologia; 2012 May; 44 Suppl 1():226-30. PubMed ID: 21671978
[TBL] [Abstract][Full Text] [Related]
36. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
Schubert M; Jockenhövel F
J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
[TBL] [Abstract][Full Text] [Related]
37. Short duration testosterone infusions maintain male sex behavior in Syrian hamsters.
Park JH; Paul MJ; Butler MP; Villa P; Burke M; Kim DP; Routman DM; Schoomer EE; Zucker I
Horm Behav; 2007 Aug; 52(2):169-76. PubMed ID: 17490666
[TBL] [Abstract][Full Text] [Related]
38. Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism.
Yamaguchi K; Ishikawa T; Chiba K; Fujisawa M
Andrologia; 2011 Feb; 43(1):52-6. PubMed ID: 21219383
[TBL] [Abstract][Full Text] [Related]
39. Toxicological considerations of Kampo medicines in clinical use.
Ikegami F; Fujii Y; Satoh T
Toxicology; 2004 May; 198(1-3):221-8. PubMed ID: 15138045
[TBL] [Abstract][Full Text] [Related]
40. Testosterone and prostate cancer: what are the risks for middle-aged men?
Morgentaler A
Urol Clin North Am; 2011 May; 38(2):119-24. PubMed ID: 21621078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
